Literature DB >> 33600578

Ddhd1 knockout mouse as a model of locomotive and physiological abnormality in familial spastic paraplegia.

Takuya Morikawa1, Hiroaki Ohishi2, Kengo Kosaka1, Tomofumi Shimojo1, Akihiro Nagano1, Itsuki Taniguchi1, Ryuta Fujioka3, Kosei Moriyama4, Motoko Unoki2, Masatomo Takahashi5, Motonao Nakao5, Yoshihiro Izumi5, Takeshi Bamba5, Hiroyuki Sasaki2, Shiroh Miura6, Hiroki Shibata1.   

Abstract

We have previously reported a novel homozygous 4-bp deletion in DDHD1 as the responsible variant for spastic paraplegia type 28 (SPG28; OMIM#609340). The variant causes a frameshift, resulting in a functionally null allele in the patient. DDHD1 encodes phospholipase A1 (PLA1) catalyzing phosphatidylinositol to lysophosphatidylinositol (LPI). To clarify the pathogenic mechanism of SPG28, we established Ddhd1 knockout mice (Ddhd1[-/-]) carrying a 5-bp deletion in Ddhd1, resulting in a premature termination of translation at a position similar to that of the patient. We observed a significant decrease in foot-base angle (FBA) in aged Ddhd1(-/-) (24 months of age) and a significant decrease in LPI 20:4 (sn-2) in Ddhd1(-/-) cerebra (26 months of age). These changes in FBA were not observed in 14 months of age. We also observed significant changes of expression levels of 22 genes in the Ddhd1(-/-) cerebra (26 months of age). Gene Ontology (GO) terms relating to the nervous system and cell-cell communications were significantly enriched. We conclude that the reduced signaling of LPI 20:4 (sn-2) by PLA1 dysfunction is responsible for the locomotive abnormality in SPG28, further suggesting that the reduction of downstream signaling such as GPR55 which is agonized by LPI is involved in the pathogenesis of SPG28.
© 2021 The Author(s).

Entities:  

Keywords:  DDHD1; PLA1; Spastic paraplegia (SPG); foot–base angle (FBA); lysophosphatidylinositol (LPI)

Mesh:

Year:  2021        PMID: 33600578      PMCID: PMC7921290          DOI: 10.1042/BSR20204171

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  29 in total

1.  Impairment of brain and muscle energy metabolism detected by magnetic resonance spectroscopy in hereditary spastic paraparesis type 28 patients with DDHD1 mutations.

Authors:  Rocco Liguori; Maria Pia Giannoccaro; Alessia Arnoldi; Andrea Citterio; Caterina Tonon; Raffaele Lodi; Nereo Bresolin; Maria Teresa Bassi
Journal:  J Neurol       Date:  2014-07-03       Impact factor: 4.849

2.  Mutations in DDHD1, encoding a phospholipase A1, is a novel cause of retinopathy and neurodegeneration with brain iron accumulation.

Authors:  Rodolphe Dard; Claire Meyniel; Valérie Touitou; Giovanni Stevanin; Foudil Lamari; Alexandra Durr; Claire Ewenczyk; Fanny Mochel
Journal:  Eur J Med Genet       Date:  2017-08-14       Impact factor: 2.708

Review 3.  The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.

Authors:  Atsushi Yamashita; Saori Oka; Takashi Tanikawa; Yasuhiro Hayashi; Yoko Nemoto-Sasaki; Takayuki Sugiura
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-05-25       Impact factor: 3.072

4.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

5.  Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in DDHD1/SPG28.

Authors:  Andrea Mignarri; Anna Rubegni; Alessandra Tessa; Stefano Stefanucci; Alessandro Malandrini; Elena Cardaioli; Maria Chiara Meschini; Maria Laura Stromillo; Stefano Doccini; Antonio Federico; Filippo Maria Santorelli; Maria Teresa Dotti
Journal:  J Neurol Sci       Date:  2016-02-04       Impact factor: 3.181

Review 6.  Hereditary spastic paraplegia.

Authors:  Craig Blackstone
Journal:  Handb Clin Neurol       Date:  2018

7.  The Spastic Paraplegia-Associated Phospholipase DDHD1 Is a Primary Brain Phosphatidylinositol Lipase.

Authors:  Jordon M Inloes; Hui Jing; Benjamin F Cravatt
Journal:  Biochemistry       Date:  2018-09-17       Impact factor: 3.162

Review 8.  Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms.

Authors:  Temistocle Lo Giudice; Federica Lombardi; Filippo Maria Santorelli; Toshitaka Kawarai; Antonio Orlacchio
Journal:  Exp Neurol       Date:  2014-06-20       Impact factor: 5.330

9.  Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.

Authors:  Yutaro Obara; Sanae Ueno; Yoshimi Yanagihata; Norimichi Nakahata
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

10.  Role of GPR55 during Axon Growth and Target Innervation.

Authors:  Hosni Cherif; Anteneh Argaw; Bruno Cécyre; Alex Bouchard; Jonathan Gagnon; Pasha Javadi; Sébastien Desgent; Ken Mackie; Jean-François Bouchard
Journal:  eNeuro       Date:  2015-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.